Technologies Inc. (ASX: VTI), a technology-focused company dedicated
to improving vision, today announced the availability of NaturalVue®
(etafilcon A) Multifocal 1 Day Contact Lenses in Plus Powers.
This press release features multimedia. View the full release here:
At AOA Visioneering Technologies Inc. announced the availability of NaturalVue® Multifocal 1 Day Contact Lenses in Plus Powers. The expansion gives NaturalVue Multifocal (NVMF) the most extensive power range available in 0.25 D steps of any daily disposable soft multifocal contact lens. (Photo: Business Wire)
The expansion of plus powers gives NaturalVue Multifocal (NVMF) the most
extensive power range available in 0.25 D steps of any daily disposable
soft multifocal contact lenses currently on the market1. The
product expansion announcement was made at the 2018
American Optometry Association (AOA) meeting in Denver.
NaturalVue Multifocal 1 Day Contact Lenses were created with technology
inspired by advanced camera optics. As a result, the lenses provide
spectacle-level vision across all distances2. Through the
added plus powers, practitioners will be able to meet the vision needs
for a wider range of patients. This expansion will take the full power
range of the lens from +4.00 to -12.25 (in 0.25D steps).
“It’s estimated that in the US at least 30 percent of adults are
hyperopic3 or farsighted. Additionally, most people become
presbyopic – age-related farsightedness – after 40 even if they have
never had a previous vision care problem4,” said Stephen
Snowdy, PhD, VTI’s CEO. “By expanding the parameters of our NVMF 1 Day
Contact Lenses to include plus powers, we are now able to provide
optometrists and their patients with a much wider array of options. Not
only does this translate to improved eyesight for more people, but also
can mean increased market potential and revenues for VTI.”
“The unique extended depth of focus design of NaturalVue Multifocal
provides precise vision at all distances. This facilitates an intuitive
fitting process which, in turn, optimizes visual performance and fitting
efficiency,” said Brett O’Connor, OD, a noted optometrist and clinical
researcher based in Jacksonville, Florida. “With the hyperopic parameter
expansion of NVMF to +4.00, I can now offer my presbyopic hyperopes a
daily disposable center-distance multifocal contact lens that delivers
maximum clarity and convenience.”
“Too many hyperopic patients are unsatisfied with traditional
multifocals,” said Doug Benoit, OD, FAAO, Executive Director of
Professional Affairs for VTI. “Now, as the number of hyperopic patients
grows, it’s critical that we provide our eye care practitioners the
highest parameter range for daily disposable contact lenses. The precise
0.25D step options of our NVMF product with plus power means they will
be able to satisfy the contact lens requirements of more patients than
NVMF plus powers will be available in 30- and 90-revenue packs as well
as 10-pack trials. The lenses are available to independent doctors of
optometry nationwide. A further parameter expansion to up to +6.00 is
planned for the future.
About Visioneering Technologies, Inc.
Visioneering Technologies, Inc. (VTI), headquartered in Atlanta,
Georgia, is an innovative company dedicated to developing products that
improve vision. With a portfolio of technologies, the company uses
creative and differentiated design approaches to develop products that
enhance practitioner and patient experiences. VTI optical designs have
been awarded twelve patents worldwide, with an additional seven pending.
Strength in science, an entrepreneurial culture, and the ability to
bring technology to life make Visioneering Technologies, Inc. a company
to watch. For more information, visit www.vtivision.com/
or call 844-884-5367, ext. 104.
Press Release: MKT-VTI-PR41 r0
1 Tyler’s Quarterly, March 2018.
2 VTI Data on file, 2015.
3 National Eye Institute. 2018. Retrieved June 11, 2018 at https://nei.nih.gov/eyedata
4 Bailey, G. (2017, August). Presbyopia. Retrieved June 11,
2018, from http://www.allaboutvision.com/conditions/presbyopia.htm
View source version on businesswire.com: https://www.businesswire.com/news/home/20180622005067/en/